Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer

Increased detection of plasma lysophosphatidic acid (LPA) has been proposed as a potential diagnostic biomarker in ovarian cancer, but inconsistency exists in these reports. It has been shown that LPA can undergo an artificial increase during sample processing and analysis, which has not been accoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Tsukasa, Shoaib, Muhammad, Kuschner, Cyrus E., Nishikimi, Mitsuaki, Becker, Lance B., Lee, Annette T., Kim, Junhwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521627/
https://www.ncbi.nlm.nih.gov/pubmed/30979045
http://dx.doi.org/10.3390/cancers11040520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521627/
https://www.ncbi.nlm.nih.gov/pubmed/30979045
http://dx.doi.org/10.3390/cancers11040520

Ejemplares similares